A series of diketopyrrolopyrrole-based fluorescent probes (DPP-C2, LysoDPP-C2, LysoDPP-C3, and LysoDPP-C4) have been developed for the detection of low pH and Zn 2+ in an AND logic fashion. The chelation of Zn 2+ or the protonation of a morpholine moiety within these probes results in a partial increase in the fluorescence intensity, an effect ascribed to suppression of one possible photo-induced electron transfer (PET) pathway. In contrast, a large increase in the observed fluorescence intensity is observed at low pH and in the presence of Zn 2+ ; this is rationalized in terms of both possible PET 
Introduction
Zinc (Zn 2+ ) is one of the most common d-block metals found in the human body. It plays an important role in a wide range of biochemical processes and is used to maintain the structural integrity of over 3000 human proteins. 1 In addition, so-called labile Zn 2+ ions are commonly found in specic areas of the human body, including the prostate. 2 In the prostate, Zn 2+ is found at concentrations between $10 to 100 mM. 3, 4 This high Zn 2+ concentration serves to inhibit m-aconitase activity thus preventing citrate oxidation during the Krebs cycle. 2, 5, 6 This unique function allows increased production and secretion of citrate into the prostatic uid and is considered vital for the normal function of the prostate. However, in malignant prostate tissue, there is a dramatic decrease in Zn 2+ concentration (500 nmol g À1 vs. 3000 nmol g À1 -for malignant and healthy tissues, respectively), as well as a downregulation of the zinc transporter, ZIP1. [7] [8] [9] [10] Indeed, strong correlations between prostatic Zn 2+ levels and prostate cancer (PCa) have been reported. 5 These correlations are providing an incentive to develop probes for Zn 2+ that may be used to image the prostate and differentiate between normal and cancerous tissues in biopsy samples. Here, we report initial efforts to develop such a probe. To date, considerable effort has been devoted to the development of Zn 2+ probes. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Fluorescence-based systems have received particular attention in this regard since they provide good sensitivity, selectivity, and spatial and temporal resolution. In 2010, Lippard, et al. reported the uorescence Zn 2+ probe, ZPP1, which was successfully used to identify PCa in a transgenic mouse model. 21 Subsequently, they developed a triphenylphosphonium (TPP) functionalized, reaction-based uorescent probe (DA-ZP1-TPP), which selectively localized at the mitochondria. On the basis of studies with this probe, it was concluded that tumorigenic cancer cells are unable to accumulate Zn 2+ within their mitochondria. 
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Lysosomes are acidic organelles with a pH (3.5-6.0) that is distinctly lower than that of the cytoplasm (pH 7.2). Within the acidic lysosomal environment, a diversity of functions is maintained, such as the digestion and degradation of macromolecules by hydrolytic enzymes. These lysosomal functions are closely linked to other cell processes, including plasma membrane repair and metabolism. 25 The abnormal function of lysosomes has been linked to the pathogenesis of a number of disorders and diseases. 25, 26 Probes that provide insight into the functioning of lysosomes may thus have a role to play in the diagnostic and staging of various diseases, including cancer.
To our knowledge, there are currently no uorescent probes that may be used to image lysosomal Zn 2+ in prostate cancer cells. We believe that a dual detection strategy that monitors both pH and Zn 2+ concentrations may allow this goal to be achieved. In recent years several research groups have focused on applying molecular logic to the problem of biological sensing. [27] [28] [29] [30] So-called AND logic-based uorescence probes are particularly attractive since they may allow two or more biological analytes to be analysed simultaneously. In this work, we focused on the development of lysosomal targeting AND logicbased uorescence probes for the detection of both acidic pH and Zn 2+ (probes DPP-C2, LysoDPP-C2, LysoDPP-C3, and LysoDPP-C4; Fig. 1 ). This AND logic approach is designed to overcome the limitations associated with monitoring Zn 2+ concentrations in the lysosome by increasing the signal-tonoise ratio between the lysosome (low pH -strong uores-cence) and cytosol (weak uorescence).
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Results and discussion
To obtain probes with dual Zn 2+ and H + sensing functions, both a methoxy-based N,N-di-(2-picolyl)ethylenediamine (MeO-DPEN) Zn 2+ chelator 34 and a lysosome-targeting morpholine moiety were appended synthetically to the lactam units of a 3,6-diphenyl diketopyrrolopyrrole (DPP) uorophore (Fig. 1) . Each of these functionalities was designed to quench the uores-cence via an independent photoinduced electron transfer (PET) pathway. In the presence of Zn 2+ , MeO-DPEN forms a chelate complex with the Zn 2+ cation. This results in a partial increase in the uorescence emission intensity through inhibition of the PET process associated with this particular subunit. When the resulting Zn 2+ probe complex is exposed to an acidic environment (e.g., enters the lysosome), the morpholine unit becomes protonated; this leads to a complete restoration of the uores-cence emission intensity since both PET pathways are now blocked. The basic mechanistic rationale underlying our probe design and expected function is shown in Scheme 1.
The synthesis of probes DPP-C2, LysoDPP-C2, LysoDPP-C3, and LysoDPP-C4 is detailed in the ESI (Schemes S1-S3 †). In brief, dye 1 was asymmetrically acylated under basic conditions with tert-butyl bromoacetate to afford intermediate 2 in 25% yield. Compound 2 was then alkylated with bromoethane or bromo-substituted alkyl morpholine intermediates containing tethers of varying lengths (n ¼ 2 and 3; precursors 3 and 4) using K 2 CO 3 as a base, NaI as a catalyst, and acetone as the solvent to afford compounds 5, 6 and 7 in 56-60% yield. To access the alkyl (n ¼ 4) morpholine functionalized DPP, intermediate 2 was alkylated with 1,4-dibromobutane using similar alkylation conditions. This afforded the bromo-alkyl intermediate 8, which was subsequently reacted with morpholine, giving compound 9 in excellent yield (79%). The tert-butyl esters of intermediates 5, 6, 7, and 9 were hydrolysed using triuoro-acetic acid to give the corresponding free carboxylic acids. Each Scheme 1 Fluorescence 'turn on' mechanism allowing for the concurrent detection of low pH AND Zn
2+
. Grey -weak fluorescence emission intensity. Green -strong fluorescence emission intensity.
carboxylic acid was taken onto the next step without purica-tion and reacted with amino functionalized MeO-DPEN to yield the desired AND logic uorescent probes DPP-C2, LysoDPP-C2, LysoDPP-C3, and LysoDPP-C4.
With each probe in hand, UV-Vis and uorescence spectroscopic analyses were performed. The polarity of the solvent was shown to have little effect on the UV-Vis absorption or uores-cence emission spectrum of each probe or the corresponding Zn 2+ /probe complex ( Fig. S1-S4 , Tables S1 and S2 †) . Interestingly, the DPP-C2/Zn 2+ complex demonstrated poor photostability with the intensity of the UV-Vis absorption and uorescence maxima being reduced by 58% and 41%, respectively, aer one week of exposure to sun light. In contrast, the morpholine-functionalized probes exhibited greater photostability with only a 33%, 26% and 20% reduction in uores-cence emission maxima being seen for (Fig. S14 and S15 †) . Next, we evaluated the ability of each probe to detect Zn 2+ at different pH. As shown in Fig. 2 , S16 and S17, † the probes proved non-uorescent in aqueous solution over the 6.5-9 pH range. As expected, the addition of Zn 2+ (1 mM) to the nonmorpholine functionalized control DPP-C2 probe resulted in the complete restoration of the uorescence emission intensity. This system also proved insensitive to pH (3.5-9) . In contrast, the addition of Zn 2+ (1 mM) to the morpholine-functionalized probes (LysoDPP-C2 and LysoDPP-C4) over a pH range of 6.5-9 led to an increase in the uorescence intensity with the largest uorescence response being produced by LysoDPP-C4. As the pH gradually became more acidic, the Zn 2+ complex of LysoDPP-C2 produced the greatest change in uorescence intensity. Moreover, the extent of PET uorescence quenching was found to decrease as the distance between the DPP subunit and the morpholine moiety increased. Per the design expectations, each morpholine-functionalized probe displayed a low uorescence emission intensity at cytosolic pH and strong uorescence emission intensity at lysosomal pH and in the presence of Zn 2+ . These results were considered as important predicates to achieving lysosomal Zn 2+ imaging with a good signal to noise ratio.
Prior to cellular studies of each probe, metal cation selectivity and competition experiments were performed. As shown in Fig. S18 , and lysosomal targeting. Low cytotoxicity was observed for each probe (Fig. S19 †) . They were thus used for cellular imaging experiments. As illustrated in Fig. 3 , upon incubation the uorescence produced by both DPP-C2 and LysoDPP-C4 was appreciable, whereas LysoDPP-C2 and LysoDPP-C3 were characterized by low levels of uorescence emission intensity. Upon the addition of N,N,N 0 ,N 0 -tetrakis(2-pyridylmethyl) ethylenediamine (TPEN), a membrane permeable zinc chelator, 35 a decrease in the uorescence emission intensity was observed in the case of each probe. In contrast, the addition of Zn 2+ in the form of zinc/pyrithione (ZnPT) 36 led to a remarkable increase in the uorescence intensity. On this basis, we concluded that probe LysoDPP-C4, in particular, was worth pursuing further as a dual mode (AND logic) intracellular Zn 2+ sensor. On the other hand, probes LysoDPP-C2 and LysoDPP-C3 were not pursued further due to their inability to produce a presumed zinc cationbased background uorescence response. The subcellular distributions of LysoDPP-C4 and the control probe DPP-C2 were then determined through co-staining experiments with LysoTracker™ Red DND-99 (Fig. 4) . LysoDPP-C4 was shown to localize at the lysosome through a close overlap with LysoTracker™ Red DND-99 producing a Pearson's coefficient (A) of 0.68 (Fig. 4d) . In accord with the design expectation that the morpholine functionality present in LysoDPP-C4 was largely responsible for the observed lysosomal targeting, the morpholine-free control DPP-C2 was shown to have a poor overlap with LysoTracker™ Red DND-99 (Pearson's coefficient of 0.17; Fig. 4h ).
LysoDPP-C4 was then tested for its ability to discriminate between cancerous and normal prostate cells. Toward this end, two prostate cancerous cell lines PC3 and DU145 and one normal human prostate epithelial cell line, RWPE1, were used. LysoDPP-C4 showed negligible cytotoxicity towards these prostate cell lines (Fig. S20 †) . Addition of Zn 2+ to the cancerous cells DU145 and PC3 resulted in no change in the uorescence intensities. However, the addition of Zn 2+ to RWPE1 cells resulted in a signicant increase in the observed uorescence intensity (Fig. 5) . This difference is ascribed to the downregulation of zinc transporters in cancerous PC3 and DU145 cells, which reduces the uptake of extracellular Zn 2+ .
Support for these ndings came from ow cytometry and ICP-MS analyses. These studies revealed that the zinc concentration-dependent uorescence enhancement could be observed only in RWPE1 cells aer incubation with Zn 2+ (15 mM), which afforded a 5.9-fold uorescence increase. An approximate 2.5-fold increase in [Zn 2+ ] in RWPE1 cells was estimated by ICP-MS using Sr 2+ as the internal standard ( Fig. S21 and Table S3 †) . On this basis, we conclude that LysoDPP-C4 may be used to discriminate between healthy and cancerous prostate cells.
On the basis of these in vitro studies, LysoDPP-C4 was tested in vivo using nude mice models (Fig. 6) . As can be seen from an inspection of Fig. 6b , injection of LysoDPP-C4 (500 mg per mouse, 5 mice per set) into male BALB/c nude mice via the tail vein resulted in a bright uorescence signal in the region of the prostate aer 15 minutes. The mice were then sacriced and dissected. The viscera were observed using a uoroscope. Both white-light color images and uorescent images were taken under the same settings ( Fig. 6c and d) . The prostate and seminal vesicle displayed a strong green uorescence, which is consistent with both literature reports that a high concentration of Zn 2+ are found in these organs and the central hypothesis underlying the present study, namely that LysoDPP-C4 is functioning as an effective Zn 2+ probe.
Histological analyses were then carried out and served to conrm the above observations (Fig. 6e) . For instance, frozen sections of the prostate and seminal vesicle produced a strong green uorescence signal, whereas little uorescence was observed in the case of the liver and kidney sections. Essentially no uorescence emission was observed in the case of the brain and muscle samples. These results provide support for our contention that LysoDPP-C4 may be used to image the prostate via Zn 2+ -induced uorescence signaling.
To test the potential of LysoDPP-C4 in prostate cancer biomedical imaging applications, a prostate nodule obtained from a 65 year-old male patient diagnosed with prostate cancer (Gleason's score, 3 + 3) was used. First, hematoxylin and eosin (H & E) staining was used to highlight the cancerous region (area within the blue line in Fig. 7a ). Subsequent staining with LysoDPP-C4 allowed a clear visualization of the cancerous regions as shown by regions of relatively low uorescence emission intensity (Fig. 7b) . A signicant difference in uorescence intensity between healthy and cancerous tissue was observed. Therefore, we propose that LysoDPP-C4 may have a role to play in identifying cancerous prostate tissue in human samples.
Experimental
All animal experiments were performed according to the Chinese Regulations for the Administration of Affairs Concerning Experimental Animals and approved by the Subcommittee on Research Animal Care at the Shanghai Ninth People's Hospital. All experimental details are provided in the ESI. † All animal experiments were performed in accord with institutional guidelines and were specically approved by the Subcommittee on Research Animal Care at the Shanghai Ninth People's Hospital.
Conclusions
In summary, we report here a series of diketopyrrolopyrrolebased AND logic uorescent probes (DPP-C2, LysoDPP-C2, LysoDPP-C3 and LysoDPP-C4) that were designed to permit the detection of both low pH and Zn 2+ in an AND logic-like fashion.
In these probes, the aliphatic morpholine moiety serves as both a pH-responsive marker and a lysosome-targeting subunit. Chelation of Zn 2+ or the protonation of the morpholine moiety serves to suppress only one PET pathway, resulting in a small increase in the observed uorescence intensity. However, when both PET pathways are blocked, as occurs in the presence of Zn 2+ and H + , the uorescence is fully recovered. The effectiveness of this strategy in terms of sensing was demonstrated through lysosomal Zn 2+ imaging in live cells. The most effective probe in terms of both initial uorescence intensity and Zn 2+ -induced increases proved to be LysoDPP-C4. This system demonstrated low cytotoxicity and permitted changes in intracellular Zn 2+ concentrations in the lysosome to be monitored. LysoDPP-C4 could be used to discriminate between cancerous and normal prostate cells. In vivo and histological studies demonstrated the effectiveness of LysoDPP-C4 in terms of identifying the prostate and to delineating cancerous regions within a prostate cancer sample obtained from a 65 year old male patient.
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